70 related articles for article (PubMed ID: 1708587)
1. [Granulopoiesis in chronic myeloproliferative disorders (CMPD): electron microscopy/morphometric investigations].
Fritsch RS; Maschek H; Ehlerding C; Widjaja W; Choritz H; Georgii A
Verh Dtsch Ges Pathol; 1990; 74():216-9. PubMed ID: 1708587
[TBL] [Abstract][Full Text] [Related]
2. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
Kreipe HH
Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
Rudzki Z; Papla B; Stachura J
Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702
[TBL] [Abstract][Full Text] [Related]
4. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
Thiele J; Funke S; Holgado S; Choritz H; Georgii A
Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
Takahashi M; Fujiwara M
Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
[No Abstract] [Full Text] [Related]
6. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
Stevens EC; Rosenthal NS
Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
[TBL] [Abstract][Full Text] [Related]
7. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
9. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
10. [Clonality and stem cell defects in the molecular pathology of chronic myeloproliferative disorders].
Kreipe H; Radzun HJ; Bartels H; von Heyden HW; Löffler H; Parwaresch MR
Verh Dtsch Ges Pathol; 1990; 74():49-64. PubMed ID: 1708635
[TBL] [Abstract][Full Text] [Related]
11. [Histomorphologic findings of the bone marrow in chronic myeloproliferative diseases].
Thiele J; Fischer R
Z Hautkr; 1989 Oct; 64(10):903-4, 909-12. PubMed ID: 2686247
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders.
Yoon SY; Tefferi A; Li CY
Haematologica; 2001 Jan; 86(1):52-7. PubMed ID: 11146571
[TBL] [Abstract][Full Text] [Related]
13. Chronic radiation-induced alteration in hematopoietic repair during preclinical phases of aplastic anemia and myeloproliferative disease: assessing unscheduled DNA synthesis responses.
Seed TM; Meyers SM
Cancer Res; 1993 Oct; 53(19):4518-27. PubMed ID: 8402623
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
15. Chronic megakaryocytic-granulocytic myelosis--an electron microscopic study including freeze-fracture. II. Granulocytes, erythrocytes, plasma cells and myeloid stroma.
Thiele J; Ballard AC; Georgii A; Vykoupil KF
Virchows Arch A Pathol Anat Histol; 1977 Aug; 375(2):129-46. PubMed ID: 143112
[TBL] [Abstract][Full Text] [Related]
16. The xid mutation affects hemopoiesis in long term cultures of murine bone marrow.
Hayashi S; Witte PL; Kincade PW
J Immunol; 1989 Jan; 142(2):444-51. PubMed ID: 2911009
[TBL] [Abstract][Full Text] [Related]
17. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
[TBL] [Abstract][Full Text] [Related]
18. Chediak-Higashi syndrome. Expression of the cytoplasmic defect by in vitro cultures of bone marrow progenitors.
Barak Y; Karov Y; Nir E; Wagner Y; Kristal H; Levin S
Am J Pediatr Hematol Oncol; 1986; 8(2):128-33. PubMed ID: 3740366
[TBL] [Abstract][Full Text] [Related]
19. Hemopoietic precursor cells in erythroleukemia.
Suda T; Miura Y; Ozawa K; Mizoguchi H; Takaku F
Stem Cells (1981); 1982; 1(4-5):224-32. PubMed ID: 6959295
[TBL] [Abstract][Full Text] [Related]
20. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
